1. Newer antipsychotics and upcoming molecules for schizophrenia

   • Melvin George
   • Radhika Amrutheshwar
   • Steven Aibor Dkhar

   Review Article 02 April 2013 Pages: 1497 - 1509

2. Association of PON1 genotype and haplotype with susceptibility to coronary artery disease and clinical outcomes in dual antiplatelet-treated Han Chinese patients

   • Yan-Hong Kang
   • Hai-Yan Lao
   • Shi-Long Zhong

   Pharmacogenetics 23 April 2013 Pages: 1511 - 1519

   

3. Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations

   • Ivanka Curkovic
   • Katharina M. Rentsch
   • Alexander Jetter

   Pharmacokinetics and Disposition 16 April 2013 Pages: 1521 - 1531

   

4. Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation

   • V. Guy-Viterbo
   • A. Scohy
   • Flora Tshinanu Musuamba

   Pharmacokinetics and Disposition 16 April 2013 Pages: 1533 - 1542

   

5. Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation

   • In-Wha Kim
   • Hwi-yeol Yun
   • Jung Mi Oh

   Pharmacokinetics and Disposition 16 April 2013 Pages: 1543 - 1551

   

6. Adherence to preventive statin therapy according to socioeconomic position

   • Helle Wallach-Kildemoes
   • Morten Andersen
   • Theis Lange

   Pharmacoepidemiology and Prescription 16 April 2013 Pages: 1553 - 1563

   

7. Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations

   • Carmen C. Franz
   • Carole Hildbrand
   • Stephan Krähenbühl

   Pharmacoepidemiology and Prescription 16 April 2013 Pages: 1565 - 1573

   

8. The prevalence and incidence of medicinal cannabis on prescription in The Netherlands

   • Arno Hazekamp
   • Eibert R. Heerdink

   Pharmacoepidemiology and Prescription 16 April 2013 Pages: 1575 - 1580

   

9. Aspects of physicians’ attitudes towards the rational use of drugs at a training and research hospital: a survey study

   • Nesrin Filiz Basaran
   • Ahmet Akici

   Pharmacoepidemiology and Prescription 16 April 2013 Pages: 1581 - 1587

10. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!

    • François Montastruc
    • Virginie Gardette
    • REAL.FR Group

    Pharmacoepidemiology and Prescription 16 April 2013 Pages: 1589 - 1597

    

11. Lazy Sunday afternoons: the negative impact of interruptions in patients’ daily routine on adherence to oral antidiabetic medication. A multilevel analysis of electronic monitoring data

    • M. Vervloet
    • P. Spreeuwenberg
    • L. van Dijk

    Pharmacoepidemiology and Prescription 16 April 2013 Pages: 1599 - 1606

    

12. Transdermal buprenorphine—interesting observations on the metabolite norbuprenorphine levels in elderly subjects

    • Nuggehally R. Srinivas

    Letter to the Editors 16 April 2013 Pages: 1607 - 1608

13. Response to the Letter to the Editor by Dr. Srinivas on the recent publication of Al-Tawil et al. on the pharmacokinetics of transdermal buprenorphine patch in the elderly

    • Helen Johnson
    • Anna-Carin Berggren

    Letter to the Editors Open access 16 April 2013 Pages: 1609 - 1610

    

14. Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics

    • Cristina Gervasoni
    • Dario Cattaneo
    • Agostino Riva

    Letter to the Editors 25 April 2013 Pages: 1611 - 1613

15. Two cases of hallucination in elderly patients due to a probable interaction between flu immunization and tramadol

    • Paolo Pellegrino
    • Carla Carnovale
    • Sonia Radice

    Letter to the Editors 25 April 2013 Pages: 1615 - 1616